StockWatch
·
Medical/Dental Instruments
InvestmentJul 29, 2026, 05:27 PM

Accuray Secures $55M Investment, Converts $40M Debt

AI Summary

Accuray Incorporated announced a comprehensive plan to strengthen its financial position, securing $55.0 million through the issuance of Series A Convertible Preferred Stock. This includes a $15.0 million cash investment and the conversion of $40.0 million in existing debt held by TCW Asset Management Company LLC. The plan also involves the cancellation of warrants for approximately 27.6 million common shares, a future reverse stock split, and new strategic partnerships with Samsung HME America and RaySearch Laboratories, alongside an expanded collaboration with Tata Consultancy Services.

Key Highlights

  • Accuray issued 55,000 shares of Series A Convertible Preferred Stock for $55.0 million.
  • TCW Asset Management made a $15.0 million cash investment.
  • $40.0 million of existing debt was converted into Series A Preferred Stock.
  • Warrants for approximately 27.6 million common shares held by investors were cancelled.
  • Company agreed to implement a reverse stock split between 1-for-15 and 1-for-40.
  • Series A Preferred Stock accrues dividends at 8% per annum and is convertible at $0.50 per share.
  • Entered non-binding LOIs with Samsung HME America and RaySearch Laboratories for strategic partnerships.
  • Expanded partnership with Tata Consultancy Services (TCS) for product development and efficiency.